Sugihara I, Ueda K, Saiki H, Hanada M, Doi H, Ishibashi T, Nakayama M, Numa R, Yamauchi K, Kawata R
Dept. of Ophthalmol., Yamaguchi Univ. School of Med., Ube, Japan.
Nippon Ganka Gakkai Zasshi. 1990 Feb;94(2):211-8.
We investigated the intraocular penetration of a new Cephem type antibiotic: Cefuzonam sodium (CZON) following intravenous and subconjunctival injection. CZON was administered to 28 eyes in 26 patients by 1 g intravenous injection (IV) and to 11 eyes in 10 patients by 20 mg/0.2 ml subconjunctival injection (SCI). The penetration level of CZON by the IV method was from less than 0.0025-3.35 micrograms/ml into aqueous humor, from less than 0.0025-0.315 microgram/mg into iris tissue and 2.7-157.5 micrograms/ml into serum. The penetration level of CZON by the SCI method was from less than 0.0025-12.8 micrograms/ml into aqueous humor, from less than 0.0025-0.0426 microgram/mg into iris tissue and 1.03-18.5 micrograms/ml into serum. The penetration level of CZON into aqueous humor by SCI was higher than by IV administration. In comparison with the penetration level of CZON and Cefotiam (CTM), both aqueous humor and serum levels of CTM were higher than those of CZON. These results suggested that therapeutic levels in aqueous humor effective against gram-positive and gram-negative pathogens were achieved with the 1 g IV and 20 mg SCI of CZON. However levels effective against Staphylococcus epidermidis were only erratically attained.
我们研究了一种新型头孢烯类抗生素——头孢唑南钠(CZON)静脉注射和结膜下注射后的眼内渗透性。对26例患者的28只眼进行了1g静脉注射(IV)给予CZON,对10例患者的11只眼进行了20mg/0.2ml结膜下注射(SCI)给予CZON。IV给药法时,CZON在房水中的渗透水平为低于0.0025 - 3.35微克/毫升,在虹膜组织中为低于0.0025 - 0.315微克/毫克,在血清中为2.7 - 157.5微克/毫升。SCI给药法时,CZON在房水中的渗透水平为低于0.0025 - 12.8微克/毫升,在虹膜组织中为低于0.0025 - 0.0426微克/毫克,在血清中为1.03 - 18.5微克/毫升。SCI给药时CZON在房水中的渗透水平高于IV给药。与头孢唑南(CZON)和头孢替安(CTM)的渗透水平相比,CTM在房水和血清中的水平均高于CZON。这些结果表明,1g IV和20mg SCI的CZON可在房水中达到对革兰氏阳性和革兰氏阴性病原体有效的治疗水平。然而,对表皮葡萄球菌有效的水平仅偶尔能达到。